Literature DB >> 8530519

Phosphorylation of both serine residues in cardiac troponin I is required to decrease the Ca2+ affinity of cardiac troponin C.

R Zhang1, J Zhao, J D Potter.   

Abstract

The phosphorylation of cardiac muscle troponin I (CTnI) at two adjacent N-terminal serine residues by cAMP-dependent protein kinase (PKA) has been implicated in the inotropic response of the heart to beta-agonists. Phosphorylation of these residues has been shown to reduce the Ca2+ affinity of the single Ca(2+)-specific regulatory site of cardiac troponin C (CTnC) and to increase the rate of Ca2+ dissociation from this site (Robertson, S. P., Johnson, J. D., Holroyde, M. J., Kranias, E. G., Potter, J. D., and Solaro, R. J. (1982) J. Biol. Chem. 257, 260-263). Recent studies (Zhang, R., Zhao, J., and Potter, J. D. (1995) Circ. Res. 76, 1028-1035) have correlated this increase in Ca2+ dissociation with a reduced Ca2+ sensitivity of force development and a faster rate of cardiac muscle relaxation in a PKA phosphorylated skinned cardiac muscle preparation. To further determine the role of the two PKA phosphorylation sites in mouse CTnI (serine 22 and 23), serine 22 or 23, or both were mutated to alanine. The wild type and the mutated CTnIs were expressed in Escherichia coli and purified. Using these mutants, it was found that serine 23 was phosphorylated more rapidly than serine 22 and that both serines are required to be phosphorylated in order to observe the characteristic reduction in the Ca2+ sensitivity of force development seen in a skinned cardiac muscle preparation. The latter result confirms that PKA phosphorylation of CTnI, and not other proteins, is responsible for this change in Ca2+ sensitivity. The results also suggest that one of the serines (23) may be constitutively phosphorylated and that serine 22 may be functionally more important.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530519     DOI: 10.1074/jbc.270.51.30773

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

Review 1.  Troponin I: inhibitor or facilitator.

Authors:  S V Perry
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Force relaxation and thin filament protein phosphorylation during acute myocardial ischemia.

Authors:  Young Soo Han; Ozgur Ogut
Journal:  Cytoskeleton (Hoboken)       Date:  2010-11-02

3.  Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart.

Authors:  R C Fentzke; S H Buck; J R Patel; H Lin; B M Wolska; M O Stojanovic; A F Martin; R J Solaro; R L Moss; J M Leiden
Journal:  J Physiol       Date:  1999-05-15       Impact factor: 5.182

Review 4.  Sarcomeric protein mutations in dilated cardiomyopathy.

Authors:  Audrey N Chang; James D Potter
Journal:  Heart Fail Rev       Date:  2005-09       Impact factor: 4.214

Review 5.  Protein phosphorylation and signal transduction in cardiac thin filaments.

Authors:  R John Solaro; Tomoyoshi Kobayashi
Journal:  J Biol Chem       Date:  2011-01-21       Impact factor: 5.157

6.  Length-dependent activation is modulated by cardiac troponin I bisphosphorylation at Ser23 and Ser24 but not by Thr143 phosphorylation.

Authors:  Paul J M Wijnker; Vasco Sequeira; D Brian Foster; Yuejin Li; Cristobal G Dos Remedios; Anne M Murphy; Ger J M Stienen; Jolanda van der Velden
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-28       Impact factor: 4.733

7.  Independent modulation of contractile performance by cardiac troponin I Ser43 and Ser45 in the dynamic sarcomere.

Authors:  Sarah E Lang; Jennifer Schwank; Tamara K Stevenson; Mark A Jensen; Margaret V Westfall
Journal:  J Mol Cell Cardiol       Date:  2014-12-03       Impact factor: 5.000

8.  Removal of the N-terminal extension of cardiac troponin I as a functional compensation for impaired myocardial beta-adrenergic signaling.

Authors:  Han-Zhong Feng; Min Chen; Lee S Weinstein; Jian-Ping Jin
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

9.  Adrenergic regulation of cardiac contractility does not involve phosphorylation of the cardiac ryanodine receptor at serine 2808.

Authors:  Scott M MacDonnell; Gerardo García-Rivas; Joseph A Scherman; Hajime Kubo; Xiongwen Chen; Héctor Valdivia; Steven R Houser
Journal:  Circ Res       Date:  2008-04-03       Impact factor: 17.367

10.  Challenging current paradigms related to cardiomyopathies. Are changes in the Ca2+ sensitivity of myofilaments containing cardiac troponin C mutations (G159D and L29Q) good predictors of the phenotypic outcomes?

Authors:  David Dweck; Nir Hus; James D Potter
Journal:  J Biol Chem       Date:  2008-09-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.